JAGX Jaguar Health, Inc.

0.3270USD-7.42%Mkt Cap: 4.36M USDP/E: —

Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. It operates through two segments, Animal He…

Key Statistics

Company
Market Cap4.36M USD
Enterprise Value-3.48M USD
Revenue (TTM)27.07M USD
Gross Profit7.74M USD
Net Income (TTM)-53.43M USD
Revenue/Share92.62 USD
Last Price0.3270 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees47
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.06
PEG—
EV/EBITDA0.16
EV/Revenue-0.13
P/S0.16
P/B0.01
EPS (TTM)-4012.65 USD
EPS (Forward)-5.68 USD
52W Range
0.29540% of range73.50
52W High73.50 USD
52W Low0.2954 USD
Profitability
Gross Margin67.21%
Oper. Margin-88.20%
EBITDA Margin-81.20%
Profit Margin-464.20%
ROE309.06%
ROA-139.43%
ROIC-188.33%
ROCE—
Growth
Revenue Growth-24.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-23.69M USD
CapEx (TTM)41.00K USD
FCF Margin-1.04%
FCF Yield-6.43%
Net Debt-2.01M USD
Net Debt/EBITDA0.09
Net Debt/FCF—
Balance Sheet
Debt/Equity-2.52
Current Ratio1.28
Quick Ratio0.49
Book Value/Sh29.69 USD
Cash/Share8.08 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateJun 7, 2019
Splits
Last Split1:15
Split DateSep 17, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.13.35M
Float575.00K
Insiders0.70%
Institutions0.36%
Short Interest
Short Ratio0.1d
Short % Float8.64%
Short % Out.8.64%
Shares Short200.78K
Short (prev mo.)84.16K
Technical
SMA 503.699 (-91.2%)
SMA 20093.65 (-99.7%)
Beta—
S&P 52W Chg12.00%
Avg Vol (30d)781.78K
Avg Vol (10d)718.80K
Technical Indicators
RSI (14)38.4
MACD-0.7798
MACD Signal-0.8472
MACD Hist.+0.0674
BB Upper2.495 USD
BB Middle0.9391 USD
BB Lower-0.6167 USD
BB Width331.35%
ATR (14)0.5109 USD
Vol Ratio (20d)0.54x

About Jaguar Health (NASDAQ: JAGX)

›

Jaguar Health (NASDAQ: JAGX) is listed on Nasdaq, where its shares trade in USD. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 47 employees.

The shares were at 0.3270 USD on 19 November 2026, down 99.5% over 52 weeks. Its 52-week range is 0.2954 USD to 73.50 USD: the price is 99.6% below the high and 10.7% above the low.

Its market capitalisation is 4.36M USD.

Jaguar Health reports return on equity of 309.1%, an operating margin of -88.2% and revenue down 24.0% year over year.

It holds more cash than debt, a net cash position of 2.01M USD. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health.